Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Helen Gika

Showing results (101-110 of 117) with videos related to

Pageof 12
Sort By:
Metabolites|September 23, 2022
Machine Learning Algorithm to Predict Obstructive Coronary Artery Disease: Insights from the CorLipid TrialEleftherios Panteris, Olga Deda, Andreas S Papazoglou, et al.
Metabolomics : Official Journal of the Metabolomic Society|August 27, 2022
Quality assurance and quality control reporting in untargeted metabolic phenotyping: mQACC recommendations for analytical quality managementJennifer A Kirwan, Helen Gika, Richard D Beger, et al.
The Analyst|November 12, 2025
Toward minimally invasive metabolomics: GC-MS metabolic fingerprints of dried blood microsamples in comparison to plasmaDaniel Marques de Sá E Silva, Marlene Thaitumu, Christina Virgiliou, et al.
International Journal of Molecular Sciences|December 11, 2022
Blood Metabolomics May Discriminate a Sub-Group of Patients with First Demyelinating Episode in the Context of RRMS with Increased Disability and MRI Characteristics Indicative of Poor PrognosisMarina Boziki, Alexandros Pechlivanis, Christina Virgiliou, et al.
JAMA Ophthalmology|December 26, 2024
Efficacy and Safety of Mydriatic Microdrops for Retinopathy of Prematurity Screening: The MyMiROPS Randomized Clinical TrialAikaterini K Seliniotaki, Maria Lithoxopoulou, Christina Virgiliou, et al.
Molecules (Basel, Switzerland)|February 11, 2023
Optimizing the Distillation of Greek Oregano-Do Process Parameters Affect Bioactive Aroma Constituents and In Vitro Antioxidant Activity?Alexandros Nakas, Georgia Giannarelli, Ioannis Fotopoulos, et al.
Trials|April 16, 2022
Efficacy and safety of Mydriatic Microdrops for Retinopathy Of Prematurity Screening (MyMiROPS): study protocol for a non-inferiority crossover randomized controlled trialAikaterini K Seliniotaki, Anna-Bettina Haidich, Maria Lithoxopoulou, et al.
Cardiovascular Diabetology|May 7, 2022
Prognostic significance of metabolomic biomarkers in patients with diabetes mellitus and coronary artery diseaseEfstratios Karagiannidis, Dimitrios V Moysidis, Andreas S Papazoglou, et al.
BMC Cardiovascular Disorders|February 9, 2021
Correlation of the severity of coronary artery disease with patients' metabolic profile- rationale, design and baseline patient characteristics of the CorLipid trialEfstratios Karagiannidis, Georgios Sofidis, Andreas S Papazoglou, et al.
Journal of Personalized Medicine|February 12, 2021
Serum Ceramides as Prognostic Biomarkers of Large Thrombus Burden in Patients with STEMI: A Micro-Computed Tomography StudyEfstratios Karagiannidis, Andreas S Papazoglou, Nikolaos Stalikas, et al.
Pageof 12

Showing results (101-110 of 117) with videos related to

Sort By:
Pageof 12
Metabolites|September 23, 2022
Machine Learning Algorithm to Predict Obstructive Coronary Artery Disease: Insights from the CorLipid TrialEleftherios Panteris, Olga Deda, Andreas S Papazoglou, et al.
Metabolomics : Official Journal of the Metabolomic Society|August 27, 2022
Quality assurance and quality control reporting in untargeted metabolic phenotyping: mQACC recommendations for analytical quality managementJennifer A Kirwan, Helen Gika, Richard D Beger, et al.
The Analyst|November 12, 2025
Toward minimally invasive metabolomics: GC-MS metabolic fingerprints of dried blood microsamples in comparison to plasmaDaniel Marques de Sá E Silva, Marlene Thaitumu, Christina Virgiliou, et al.
International Journal of Molecular Sciences|December 11, 2022
Blood Metabolomics May Discriminate a Sub-Group of Patients with First Demyelinating Episode in the Context of RRMS with Increased Disability and MRI Characteristics Indicative of Poor PrognosisMarina Boziki, Alexandros Pechlivanis, Christina Virgiliou, et al.
JAMA Ophthalmology|December 26, 2024
Efficacy and Safety of Mydriatic Microdrops for Retinopathy of Prematurity Screening: The MyMiROPS Randomized Clinical TrialAikaterini K Seliniotaki, Maria Lithoxopoulou, Christina Virgiliou, et al.
Molecules (Basel, Switzerland)|February 11, 2023
Optimizing the Distillation of Greek Oregano-Do Process Parameters Affect Bioactive Aroma Constituents and In Vitro Antioxidant Activity?Alexandros Nakas, Georgia Giannarelli, Ioannis Fotopoulos, et al.
Trials|April 16, 2022
Efficacy and safety of Mydriatic Microdrops for Retinopathy Of Prematurity Screening (MyMiROPS): study protocol for a non-inferiority crossover randomized controlled trialAikaterini K Seliniotaki, Anna-Bettina Haidich, Maria Lithoxopoulou, et al.
Cardiovascular Diabetology|May 7, 2022
Prognostic significance of metabolomic biomarkers in patients with diabetes mellitus and coronary artery diseaseEfstratios Karagiannidis, Dimitrios V Moysidis, Andreas S Papazoglou, et al.
BMC Cardiovascular Disorders|February 9, 2021
Correlation of the severity of coronary artery disease with patients' metabolic profile- rationale, design and baseline patient characteristics of the CorLipid trialEfstratios Karagiannidis, Georgios Sofidis, Andreas S Papazoglou, et al.
Journal of Personalized Medicine|February 12, 2021
Serum Ceramides as Prognostic Biomarkers of Large Thrombus Burden in Patients with STEMI: A Micro-Computed Tomography StudyEfstratios Karagiannidis, Andreas S Papazoglou, Nikolaos Stalikas, et al.
Pageof 12